Profile
ACB ZTS HLN TAK TEVA VTRS
Company Name Aurora Cannabis Inc. Zoetis Inc. Haleon plc Takeda Pharmaceutical Company Limited Teva Pharmaceutical Industries Limited Viatris Inc.
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Drug Manufacturers - Specialty & Generic Drug Manufacturers - Specialty & Generic Drug Manufacturers - Specialty & Generic Drug Manufacturers - Specialty & Generic Drug Manufacturers - Specialty & Generic Drug Manufacturers - Specialty & Generic
Market Cap $238.17M $74.68B $43.64B $41.66B $25.66B $14.99B
Employees 1.07K 14.10K 25.41K 49.28K 37.00K 32.00K
CEO Mr. Miguel Martin Ms. Kristin C. Peck Mr. Brian James McNamara Mr. Christophe Weber Mr. Richard D. Francis Mr. Scott Andrew Smith Ph.D.
Ratings
ACB ZTS HLN TAK TEVA VTRS
Quant Rating Score 2 3 3 3 1 3
Quant Rating Sell Neutral Neutral Neutral Strong Sell Neutral
Trading
ACB ZTS HLN TAK TEVA VTRS
Last Close $4.34 $165.52 $9.74 $13.14 $22.62 $12.56
High 52 $9.23 $199.94 $10.69 $15.08 $22.62 $13.53
Low 52 $0.38 $145.54 $8.01 $12.6 $10.44 $10.05
Price vs. 52 Week High -52.98 % -17.22 % -8.89 % -12.86 % 0 % -7.17 %
Price vs. 52 Week Low 1042.11 % 13.73 % 21.6 % 4.29 % 116.67 % 24.98 %
Total Return
ACB ZTS HLN TAK TEVA VTRS
1 Month Return -4.41 % -6.35 % 0.21 % -3.17 % 36.51 % -4.99 %
3 Month Return -25.68 % -15.04 % -8.72 % -9.63 % 29.55 % 8.74 %
6 Month Return -8.25 % -6.2 % 15.54 % 1.78 % 39.11 % 19.85 %
9 Month Return -8.63 % -1.77 % 14.19 % -7.4 % 56.76 % 6.17 %
YTD Return 811.38 % -16.14 % 18.35 % -7.92 % 116.67 % 15.97 %
1 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
ACB ZTS HLN TAK TEVA VTRS
Dividend Yield Percentage (TTM) - 1.04 % 1.64 % 4.58 % - 3.82 %
Dividend Paid and Capex Coverage Ration (TTM) -3.86 % 2.1 % - 1.34 % 3.8 % 2.39 %
Dividend Per Share (TTM) - 1.73 % 0.06 % 192 % - 0.48 %
Payout Ratio (TTM) - 31.44 % - 101.62 % - -65.15 %
Growth
ACB ZTS HLN TAK TEVA VTRS
Asset Growth -9.46 % -4.28 % -2.18 % 8.25 % -1.2 % -4.67 %
Gross Profit Growth 304.26 % 3.7 % 5.84 % 1.76 % 9.65 % -0.9 %
Revenue Growth 15.86 % 5.74 % 4.09 % 5.87 % 6.17 % -5.14 %
Revenue 3 Year -60.7 % 31.98 % 13.9 % 31.78 % -6.91 % -35.32 %
Revenue 5 Year -98.47 % 53.64 % 32.87 % 147.38 % -23.33 % -41.73 %
Revenue 10 Year - 103.1 % 32.87 % 151.81 % -40.82 % -26.57 %
EBIT Growth 81.73 % 6.27 % 9.37 % -56.36 % -84.52 % -52.55 %
Net Income Growth 73.87 % 10.88 % -1.04 % -54.56 % 76.24 % -97.37 %
Net Income 3 Yeari Growth Per Share 96.44 % 47.55 % -8.67 % -62.13 % 86.29 % 104.09 %
Net Income 5 Yeari Growth Per Share 99.66 % 71.94 % 59.66 % 60.64 % 76.28 % -93.3 %
Net Income 10 Yeari Growth Per Share -392.1 % 404.24 % 59.66 % 34.95 % -133.42 % -97.12 %
Operating Income Growth 81.73 % 6.27 % 9.37 % -56.36 % -84.52 % -52.55 %
Operating Cash Flow Growth (CFG) 40.85 % 23.06 % 1.79 % -26.69 % -13.96 % -5.18 %
Operating 3 Year CFG 88.4 % 14.12 % 48.8 % -29.96 % 10.09 % 13.84 %
Operating 5 Year CFG 99.5 % 37.69 % 166.36 % 165.35 % -48.98 % -48.37 %
Operating 10 Year CFG -1290.43 % 274.61 % 166.36 % 382.49 % -67.94 % -16.8 %
EPS Growth 82.24 % 12.64 % - -55.38 % 76.42 % -97.33 %
EPS Diluted Growth 82.24 % 12.92 % - -54.86 % 76.42 % -97.35 %
Book Value Per Share -20.79 % 15.25 % 1.35 % 12.4 % -7.25 % -1.92 %
Share Holder 3 Year Equity Growth Per Share -90.2 % 36.7 % -36.6 % 38.97 % -26.74 % -55.34 %
Share Holder 5 Year Equity Growth Per Share -99.82 % 139.55 % -39.41 % 71.52 % -53.44 % -27.35 %
Share Holder 10 Year Equity Growth Per Share 1073.53 % 476.36 % -39.41 % 194.11 % -74.76 % 128.81 %
Dividend Per Share Growth - 15.15 % -85.58 % 0.92 % - -0.06 %
Dividend 3 Year Growth Per Share - 87.76 % -83.69 % 0.17 % - -
Dividend 5 Year Growth Per Share - 198.29 % -66.42 % 144.45 % -100 % -
Dividend 10 Year Growth Per Share - 665.58 % -66.42 % 101.87 % -100 % -
Debt Growth -53.94 % -16.5 % -9.43 % 24.67 % -6.53 % -4.64 %
Free Cash Flow Growth 33.21 % 22.25 % 1.67 % -31.4 % -19.19 % -7.35 %
Updated On 31 Mar 2024 31 Dec 2023 31 Dec 2023 31 Mar 2024 31 Dec 2023 31 Dec 2023
Profitability
ACB ZTS HLN TAK TEVA VTRS
Gross Profit Margin TTM 44.74 % 68.87 % 60.68 % 55.23 % 49.84 % 40.26 %
Return on Assets TTM -79.03 % 16.93 % 3.26 % 1.99 % -2.38 % -1.97 %
Return on Equity TTM -118.26 % 47.99 % 6.54 % 4.04 % -14.6 % -4.43 %
Return on Capital Employed TTM -13.47 % 26.36 % 7.22 % 4.18 % 1.6 % -0.71 %
Net Income Per EBT TTM 100.57 % 79.65 % 65.38 % 108.74 % 176.38 % 92.81 %
EBT Per Ebit TTM 685.07 % 91.46 % 82.95 % 52.35 % -125.67 % 359.67 %
EBIT Per Revenue TTM -39.19 % 36.45 % 17.82 % 11.21 % 2.67 % -1.76 %
Cash Flow To Debt Ratio TTM -80.08 % 44.8 % - 16.58 % 9.78 % 13.05 %
Receivables Turnover TTM 5.41 6.49 5.27 6.3 4.84 3.81
Payables Turnover TTM 6.67 7.05 1.23 4.92 3.55 7.23
Inventory Turnover TTM 0.73 1.18 3.03 1.69 2.12 2.2
Fixed Asset Turnover TTM 83.4 % 259.93 % 604.62 % 240.84 % 277.85 % 561.67 %
Asset Turnover TTM 29.27 % 63.75 % 33.71 % 31.2 % 40.16 % 33.6 %
Operating Cash Flow Per Share TTM -1.77 6.5 - 528.88 1.64 1.93
Free Cash Flow Per Share TTM -2.23 5.1 - 321.24 1.21 1.6
Cash Per Share TTM 247.72 % 378.45 % 5.72 % 57241.03 % 292.94 % 171.57 %
Operating Cash Flow Sales Ratio TTM -34.19 % 32.18 % - 18.42 % 11.07 % 15.29 %
Free Cash Flow Operating Cash Flow Ratio TTM 125.88 % 78.37 % - 60.74 % 73.71 % 83.19 %
Cash Flow Coverage Ratios TTM -80.08 % 44.8 % - 16.58 % 9.78 % 13.05 %
Price To Free Cash Flows Ratio TTM -3.25 32.36 - 13.05 18.55 7.84
Price To Operating Cash Flows Ratio TTM -3.53 25.45 - 7.92 13.66 6.52
Price Cash Flow Ratio TTM -3.53 25.45 - 7.92 13.66 6.52
Income Statement (TTM)
ACB ZTS HLN TAK TEVA VTRS
Revenue $0.27B $8.54B $11.3B $4263.76B $15.85B $15.43B
Gross Profit $0.13B $5.83B $6.96B $2832.26B $7.65B $6.44B
Gross Profit Ratio 48.64% 68.28% 61.59% 66.43% 48.25% 41.74%
EBITDA $0.02B $3.69B $2.35B $874.6B $1.57B $3.46B
Net Income $-0.07B $2.34B $1.05B $144.07B $-0.56B $0.05B
EPS Diluted -1.46 5.07 0.11 91.16 -0.5 0.05
Balance Sheet (MRQ)
ACB ZTS HLN TAK TEVA VTRS
Long Term Debt $0.05B $6.75B $8.8B $5029.93B $18.48B $16.35B
Total Liabilities $0.24B $9.3B $17.33B $7834.79B $35.35B $27.22B
Total Equity $0.6B $4.99B $16.73B $7274.01B $8.13B $20.47B
Total Investments $0B $0.02B $0.07B $445.7B $0.01B $1.33B
Total Debt $0.1B $6.76B $9.46B $4843.75B $20.15B $18.37B
Total Assets $0.84B $14.29B $34.06B $15108.79B $43.48B $47.69B
Cash Flow Statement (TTM)
ACB ZTS HLN TAK TEVA VTRS
Net Income $-0.06B $2.34B $1.11B $144.07B $-0.62B $0.05B
Inventory $0B $-0.36B $-0.13B $-115.74B $0B $-0.61B
Dividends Paid $0B $-0.69B $-0.39B $-287.19B $0B $-0.58B
Operating Cash Flow $-0.07B $2.35B $2.1B $716.34B $1.37B $2.8B
Capital Expenditure $-0.02B $-0.73B $-0.34B $-480.73B $-0.53B $-0.47B
Related Stocks
Ticker Name Price
ACOR Acorda Therapeutics, Inc. 0.661
ACRX AcelRx Pharmaceuticals, Inc. 0.86
ADMP Adamis Pharmaceuticals Corporation 0.775
ADMS Adamas Pharmaceuticals, Inc. 8.22
AERI Aerie Pharmaceuticals, Inc. 15.25
AGRX Agile Therapeutics, Inc. 1.51
AKAN Akanda Corp. 1.51
ALIM Alimera Sciences, Inc. 5.54
ALVO Alvotech 12.57
ALVOW Alvotech 3.27
AMPH Amphastar Pharmaceuticals, Inc. 37.5144
AMRX Amneal Pharmaceuticals, Inc. 7.765
AMYT Amryt Pharma plc 14.7
ANIP ANI Pharmaceuticals, Inc. 54.72
AQST Aquestive Therapeutics, Inc. 3.495
ASRT Assertio Holdings, Inc. 0.8716
ATNX Athenex, Inc. 0.2031
AVDL Avadel Pharmaceuticals plc 10.37
AYTU Aytu BioPharma, Inc. 1.51
BDSI BioDelivery Sciences International, Inc. 5.59
ETFs With Exposure to ACB
Ticker ETF Name Weight Percentage Price
MJ ETFMG Alternative Harvest ETF 3.62 2.22
ONEQ Fidelity Nasdaq Composite Index ETF 0.01 77.274
PDN Invesco FTSE RAFI Developed Markets ex-U.S. Small-Mid ETF 0.015 31.65
VALT ETFMG Sit Ultra Short ETF 3.29 48.52
THCX The Cannabis ETF 3.84 16.5963
POTX Global X Cannabis ETF 1.13 5.15
TOKE Cambria Cannabis ETF 2.27 5.11
DFAI Dimensional International Core Equity Market ETF 0.000538 29.285
SILX ETFMG Prime 2x Daily Junior Silver Miners ETF 2.79 1.75
BAD B.A.D. ETF 2.16 11.91
DFIC Dimensional International Core Equity 2 ETF 0.000345 25.89
DFIS Dimensional International Small Cap ETF 0.002271 24.5175
DFSI Dimensional International Sustainability Core 1 ETF 0 33.01
IUSN.DE iShares MSCI World Small Cap UCITS ETF 0.00185 7.269
DFAX Dimensional World ex U.S. Core Equity 2 ETF 0 24.98
CBUG.DE iShares MSCI World Small Cap ESG Enhanced UCITS ETF 0.00038 4.955
DXIV Dimensional ETF Trust 0.00085629 48.2501
Unlock